When we measured cdr2 levels in the SN of post-mortem PD patients and age-matched controls (Figure 3a), we interestingly observed a significant decrease in cdr2 levels in all four PD brains, whereas levels of HSP70, a molecular chaperone, were not altered (Figure 3b). Here, CDR2 is linked to Parkinson disease.